Log in to save to my catalogue

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2674754474

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

About this item

Full title

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Gastroenterology & hepatology, 2022-10, Vol.19 (10), p.670-681

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal causes of cancer-related death worldwide. The treatment of HCC remains challenging and is largely predicated on early diagnosis. Surveillance of high-risk groups using abdominal ultrasonography, with or without serum analysis of α-fetoprotein (AFP), can permit detection of early...

Alternative Titles

Full title

Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2674754474

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2674754474

Other Identifiers

ISSN

1759-5045

E-ISSN

1759-5053

DOI

10.1038/s41575-022-00620-y

How to access this item